The Angels Initiative is a unique healthcare approach to improve care for people who have just suffered a stroke (acute stroke care) across Europe and in emerging markets.
The Angels Initiative announced today at the European Stroke
Organisation Conference (ESOC) 2019 in Milan that their three-year goal
to create a network of 1,500 stroke-ready centres and hospitals across
Europe has been achieved.
The Angels Initiative is a unique healthcare approach to improve care
for people who have just suffered a stroke (acute stroke care) across
Europe and in emerging markets. It is run by Boehringer Ingelheim in
partnership with the European Stroke Organisation (ESO), the World
Stroke Organisation (WSO), the Stroke Alliance for Europe (SAFE) and
many other national stroke societies and companies.
“Stroke is one of the leading causes of disability and death. And when a
stroke strikes, every second counts to deliver optimised care as fast as
possible to preserve life and minimise disability,” commented Prof.
Valeria Caso, past president of the ESO. “There is a need to vastly
improve the quality and speed of stroke care in Europe. I’m delighted
that through the Angels Initiative, we are collectively making a real
change, having already established thousands of participating clinics,
and the work will keep going.”
If stroke patients are treated as quickly as possible and according to
best standard of care in dedicated stroke centres, their chances of
survival and a disability-free life can be improved dramatically.
The Angels Initiative aims to improve stroke care by building acute
stroke networks, optimising treatment processes and sharing knowledge to
set-up specialised stroke-units. The common goal is to improve care for
as many people as possible who have suffered a stroke and thus save
lives. Started in 2016, the Angels Initiative has now established a
community of more than 2,700 stroke-centres and stroke ready hospitals
in 95 countries worldwide including 37 European countries.
“This is a huge achievement for the Angels Initiative in a very short
period of time. At Boehringer Ingelheim we are proud to be part of this
driving force, making a change for thousands of patients,” commented
Thomas Fischer, Global Head of the Angels Initiative at Boehringer
Ingelheim. “We have completed training in clinics in 37 European
countries, but our work does not stop here. We will continue to upskill
and support new fully-functional stroke-units in Europe and emerging
As an ongoing commitment to the community, the Angels Initiative and ESO
recognise clinics that are helping to drive the change for better,
faster stroke care, through the ESO Angels Awards. During an award
ceremony at ESOC today, 331 clinics across Europe have been recognised
with ESO Angels Awards for leading the way through fully-optimised
About the Angels Initiative
Suffering a stroke is one of the
most devastating medical emergencies that can happen to a person.
Fifteen million people worldwide suffer a stroke every year; one-third
of these people die as a consequence; another third are left permanently
disabled.1,2 Guidelines recommend that patients who have had
a stroke are treated in a specialised stroke unit by a dedicated team.
In turn, treatment should be initiated as quickly as possible after
onset of symptoms3,4 but this does not always happen.
A dedicated team of Angels consultants provide doctors, nurses and
ambulance crews with the training and support they need to create and
improve the treatment pathways and processes around stroke care. The
Angels consultants run assessments together with the hospitals; compare
existing processes with guidelines; provide training and ongoing support
for the hospital staff as well as process- and quality-monitoring.
Examples of these measures include checklists, which help to standardise
processes and to limit unnecessary delays. In addition, the Angels
Initiative offers educational tools and programmes – digital as well as
analogue, support for pre- and in-hospital process optimisation and a
community platform for peer-to-peer exchange and access to the world’s
leading stroke specialists.
For further information on the Angels Initiative, visit: https://www.angels-initiative.com/
Please click on the following link for ‘Notes to Editors’ and
This press release is issued from our
Corporate Headquarters in Ingelheim, Germany and is intended to provide
information about our global business. It is directed to the
international audience outside Germany. Please be aware that information
relating to the approval status and labels of approved products may vary
from country to country, and a country-specific press release on this
topic may have been issued in the countries where we do business.